THE COST-EFFECTIVENESS OF ABATACEPT IN COMBINATION WITH METHOTREXATE FOR THE TREATMENT OF PATIENT WITH ACTIVE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO METHOTREXATE IN THE UNITED KINGDOM

被引：0
|
作者：
Lebmeier, M. [1 ]
Pericleous, L. [1 ]
Drost, P. [2 ]
Dequen, P. [3 ]
Ouwens, M. [4 ]
Bergman, G.
Baig, H. [1 ]
机构：
[1] Bristol Myers Squibb Pharmaceut Co, Uxbridge, Middx, England
[2] Bristol Myers Squibb, Braine Ialleud, Belgium
[3] Mapi Values, Bollington, Cheshire, England
[4] Mapi Values, Houten, Netherlands
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72190-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A309 / A309
页数：1
相关论文
共 50 条
  • [41] ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    VALUE IN HEALTH, 2013, 16 (03) : A223 - A224
  • [42] AN EXPLORATORY EVALUATION OF THE COST-EFFECTIVENESS OF RITUXIMAB AND ABATACEPT IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS AFTER AN INADEQUATE RESPONSE TO A TUMOUR NECROSIS FACTOR INHIBITOR IN CANADA
    Yunger, S.
    Mistry, B.
    VALUE IN HEALTH, 2009, 12 (03) : A70 - A70
  • [43] Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate
    Stein, CM
    Pincus, T
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S47 - S52
  • [44] Combination of sulphasalazine and methotrexate in the treatment of rheumatoid arthritis
    Dougados, M
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1998, 57 (01): : 31 - 33
  • [45] COST-EFFECTIVENESS OF ABATACEPT OR INFLIXIMAB IN RHEUMATOID ARTHRITIS IN COLOMBIA
    Alfonso-Cristancho, R.
    Aiello, E. C.
    Roa, C. N.
    VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
  • [46] Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate
    Buch, Maya H.
    Walker, David
    Edwards, Christopher J.
    Barry, Jane
    Akroyd, Laura
    Omoruyi, Edmund V. Ekoka
    Taylor, Peter C.
    RHEUMATOLOGY, 2024,
  • [47] Combination of sulphasalazine and methotrexate in the treatment of rheumatoid arthritis
    M. Dougados
    Zeitschrift für Rheumatologie, 1998, 57 : 31 - 33
  • [48] Long-term efficacy and safety of abatacept through 5 years of treatment in rheumatoid arthritis patients with an inadequate response to methotrexate
    Emery, P.
    Kremer, J.
    Moreland, L.
    Russell, A.
    Li, T.
    Aranda, R.
    Becker, J. C.
    Tsai, K.
    Dougados, M.
    Westhovens, R.
    RHEUMATOLOGY, 2008, 47 : II48 - II48
  • [49] WHICH STRATEGIES IN RHEUMATOID ARTHRITIS PATIENT WITH INADEQUATE RESPONSE TO METHOTREXATE MONOTHERAPY: THE STRATEGE STUDY
    Flipo, R. -M.
    Gaujoux-Viala, C.
    Hudry, C.
    Zinovieva, E.
    Leutenegger, E.
    Herman-Demars, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 109 - 109
  • [50] Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
    SiNi Li
    JianHe Li
    LiuBao Peng
    YaMin Li
    XiaoMin Wan
    Rheumatology and Therapy, 2021, 8 : 863 - 876
12345